glp 1 receptor agonist market GLP-1 Size & Share Report, 2032 Glucagon Like Peptide-1 (GLP-1) Agonists
Description
Understand how to get it and whats changing this year.

Although lipid profiles, HbA1c, and FBG were unaffected, GLP-1 RA was linked to a slight reduction in SBP (SMD 0.20

GLP-1 stands for Glucagon-Like Peptide-1

Yabut and Drucker discuss clinical and preclinical evidence about the potential roles of GLP-1 medicines on cancer incidence, development and therapy and speculate about their mechanism on cancer cells and the tumor microenvironment.

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

Results We screened 10,670 studies and ultimately identified 5 eligible studies, encompassing 719 patients
